Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-08-021195
Filing Date
2008-03-31
Accepted
2008-03-31 15:43:41
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a08-2942_110k.htm 10-K 1636908
2 EX-10.15 a08-2942_1ex10d15.htm EX-10.15 520076
3 EX-14.1 a08-2942_1ex14d1.htm EX-14.1 85665
4 EX-21.1 a08-2942_1ex21d1.htm EX-21.1 7361
5 EX-31.1 a08-2942_1ex31d1.htm EX-31.1 12455
6 EX-31.2 a08-2942_1ex31d2.htm EX-31.2 12861
7 EX-32.1 a08-2942_1ex32d1.htm EX-32.1 8472
8 GRAPHIC g29421kc09i001.jpg GRAPHIC 25247
9 GRAPHIC g29421kc09i002.jpg GRAPHIC 66666
10 GRAPHIC g29421kc09i003.jpg GRAPHIC 2645
  Complete submission text file 0001104659-08-021195.txt   2416068
Mailing Address 1444 WAZEE STREET SUITE 210 DENVER CO 80202
Business Address 1444 WAZEE STREET SUITE 210 DENVER CO 80202 7209466440
CERAGENIX PHARMACEUTICALS, INC. (Filer) CIK: 0001180743 (see all company filings)

EIN.: 841561463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50470 | Film No.: 08724421
SIC: 3841 Surgical & Medical Instruments & Apparatus